Vilma Arce Gorvel

Title: Vilma Arce Gorvel: Innovator in Vaccine Development

Introduction

Vilma Arce Gorvel is a prominent inventor based in Marseille, France. She has made significant contributions to the field of vaccine development, particularly through her innovative work with modified gram-negative bacteria.

Latest Patents

Vilma Arce Gorvel holds two patents related to her groundbreaking research. Her latest patents focus on modified gram-negative bacteria for use as vaccines. The invention involves Gram-negative bacteria that carry an inactivated gene encoding a glycosyltransferase, which is crucial for synthesizing the core of the lipopolysaccharide (LPS) of these bacteria. The inactivated gene leads to the production of a modified LPS core. These strains exhibit attenuated virulence while effectively inducing humoral immunity, which is essential for ensuring vaccination of the host.

Career Highlights

Throughout her career, Vilma has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her work has been pivotal in advancing the understanding and application of bacterial vaccines.

Collaborations

Vilma has collaborated with notable colleagues, including Jean-Pierre Gorvel and Maite Iriarte. These partnerships have further enriched her research and contributed to her success in the field.

Conclusion

Vilma Arce Gorvel's innovative work in vaccine development showcases her dedication to advancing medical science. Her contributions through her patents and collaborations highlight her role as a leading inventor in the field.